Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Clariant’s Mevopur ProTect O2 scavenger could extend shelf life of pharma packaging

By Sean Whooley | February 13, 2020

Clariant Plastics & Coatings Healthcare Polymer Solutions announced that it is adding an oxygen-scavenging additive masterbatch to its Mevopur line of materials and services for pharmaceutical packaging and medical devices.

The Mevopur ProTect is designed to limit oxygen degradation of drugs and neutraceuticals that are stored in polyethylene terephthalate (PET) bottles, even in a transparent mono-layer construction, according to a news release.

Holden, Mass.–based Clariant said the Mevopur range of products helps manufacturers of pharmaceutical packaging and medical devices reduce the risk of regulatory non-compliance while meeting the standards for performance and appearance.

Mevopur ProTect was set to be unveiled, along with other innovations from Clariant, at Pharmapack Europe in Paris last week.

“Just as in food and beverage packaging PET is becoming more widely used,” Clariant global head of marketing & business Steve Duckworth said in a news release. “Although HDPE has been the material of choice, PET offers several advantages, including transparency, and the Mevopur ProTect additives help to combine transparency with long-term shelf-life. And, while recycling is not yet a major topic in pharma, PET is considered a highly recyclable material, and any oxygen barrier that does not require multiple layers is going to be an advantage.”

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE